New England Journal of Medicine Publishes Editorial: Prepare the Way for Hemophilia A Gene Therapy
Significantly Reduced Bleeding and Factor VIII Utilization Compared to Baseline Factor VIII Prophylactic Therapy
Mean Annualized Bleeding Rate (ABR) Reduced by 84% (p-value